We are live on ! Find out more
MDVN

MEDIVATION, INC.
MDVN

Delisted

MDVN was delisted on the 27th of September, 2016.

207 hedge funds and large institutions have $4.19B invested in MEDIVATION, INC. in 2013 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 70 increasing their positions, 68 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 36 (+3)

87% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 23

68% more call options, than puts

Call options by funds: $241M | Put options by funds: $143M

17% more capital invested

Capital invested by funds: $3.57B → $4.19B (+$613M)

10% more funds holding

Funds holding: 188207 (+19)

3% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 68

Holders
207
Holders Change
+19
Holders Change %
+10.11%
% of All Funds
6.71%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.19%
New
43
Increased
70
Reduced
68
Closed
23
Calls
$241M
Puts
$143M
Net Calls
+$97.9M
Net Calls Change
+$61.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$676M +$55.6M +1,948,288 +9%
JHIU
2
Janus Henderson Investors US
Colorado
$311M -$10.4M -365,206 -3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$242M +$6.72M +235,518 +3%
Franklin Resources
4
Franklin Resources
California
$198M +$41.1M +1,440,958 +28%
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$185M -$8.82M -308,800 -5%
KCM
6
Knoll Capital Management
Florida
$149M -$1.14M -40,000 -0.8%
O
7
OrbiMed
New York
$137M +$46.4M +1,624,800 +55%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$124M +$21.8M +764,600 +23%
Wells Fargo
9
Wells Fargo
California
$123M +$17.2M +603,772 +17%
BIT
10
BlackRock Institutional Trust
California
$107M -$3.41M -119,608 -3%
Deutsche Bank
11
Deutsche Bank
Germany
$91.5M -$4.97M -173,962 -5%
BB
12
BB Biotech
Switzerland
$86.9M
O
13
OppenheimerFunds
New York
$83.5M -$23.8M -832,452 -23%
Invesco
14
Invesco
Georgia
$83.3M +$2.85M +99,734 +4%
BFA
15
BlackRock Fund Advisors
California
$81.3M +$9.28M +325,086 +14%
Goldman Sachs
16
Goldman Sachs
New York
$73.8M -$412K -14,432 -0.6%
State Street
17
State Street
Massachusetts
$73.7M -$11.7M -410,904 -14%
Norges Bank
18
Norges Bank
Norway
$62M +$42.9M +1,504,350 +267%
WRF
19
Waddell & Reed Financial
Kansas
$61.9M +$59M +2,066,932 New
SAM
20
Sectoral Asset Management
Quebec, Canada
$60.8M -$97.3M -3,407,288 -63%
D.E. Shaw & Co
21
D.E. Shaw & Co
New York
$56.1M +$11.3M +395,720 +27%
TCIM
22
TIAA CREF Investment Management
New York
$52M -$3.65M -127,782 -7%
RIM
23
Rainier Investment Management
Washington
$50.1M -$7.72M -270,400 -14%
BCPEM
24
Bain Capital Public Equity Management
Massachusetts
$49.5M -$74.3M -2,602,776 -61%
Allianz Asset Management
25
Allianz Asset Management
Germany
$45.4M +$11.2M +392,170 +35%

MDVN Hedge Fund Activity: Q3 2013 in Review

207 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in MEDIVATION, INC. (MDVN) for Q3 2013, worth a combined $4.19B — up 17% from $3.57B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new MDVN positions and 23 closed out — a net gain of 20 holders — while 70 added to existing stakes and 68 trimmed.

The largest buyer was Waddell & Reed Financial, opening a new position worth an estimated $59M. The largest seller was PFM Health Sciences, cutting an estimated $98.1M.

  • 207 institutional investors held MEDIVATION, INC. (MDVN) as of Q3 2013, up from 188 in Q2 2013.
  • Funds reported $4.19B of MEDIVATION, INC. stock for Q3 2013, up 17% quarter-over-quarter.
  • 43 funds opened new MEDIVATION, INC. positions in Q3 2013 and 23 closed out, a net change of +20 holders.
  • The largest MEDIVATION, INC. buyer in Q3 2013 was Waddell & Reed Financial, an estimated $59M added.
  • The largest MEDIVATION, INC. seller in Q3 2013 was PFM Health Sciences, an estimated $98.1M sold.

Based on aggregated 13F filings for Q3 2013.